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ABSTRACT
Evidence from knockout studies in male mice and from experiments in male rats,
in which expression of the estrogen receptor alpha (ERα) gene was inhibited in the
medial preoptic area (MPO), suggests that ERα is important in the control of male rat
mating behavior. Therefore, in this experiment, we tested the hypothesis that activation of
ERα in the MPO is sufficient to maintain mating behavior in castrated male rats receiving
subcutaneously (s.c.) dihydrotestosterone (DHT), a non-aromatizable androgen.
Accordingly, castrated rats treated with DHT s.c. received MPO implants of either: (i)
propyl-pyrazole-triol (PPT) (Stauffer, et al 2000; Katzenellenbogen, et al 2000), a
selective ERα agonist, (ii) E2 (positive controls) or (iii) cholesterol (negative controls)
and sexual behavior was monitored. PPT was as effective as E2 at maintaining mating
behavior suggesting that, in the MPO, ERα is sufficient to mediate responses to E2 that
underlie male rat mating behavior.
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IMPLANTS OF A SELECTIVE ESTROGEN RECEPTOR ALPHA AGONIST TO
THE MALE RAT MEDIAL PREOPTIC AREA MAINTAINS MATING
BEHAVIOR

INTRODUCTION
The medial preoptic area (MPO) is located in the forebrain in the rostral
hypothalamus and plays a key role in the expression of male mating behavior (Simerly,
2002). Male rats with MPO lesion showed highly suppressed levels of mounting and
intromission and are completely unable to ejaculate (Liu et al., 1997), suggesting that the
MPO is necessary for ejaculation. Similarly, lesions of the male rat medial amygdala
(MEA) also compromise mating behavior by reducing mounting and intromission,
consistent with the possibility that motivation and sexual arousal are decreased (Kondo,
1992). Both testosterone (T) and its androgenic (DHT) and estrogenic (E2) metabolites
act in the MPO and both types of metabolites are necessary for mating behavior to occur
(Morali, 1986; Christensen et al., 1986). Implant of testosterone propionate (TP) in the
MPO maintains copulatory behavior in castrated male rats including mounting,
intromission, and ejaculation (Morali, 1986), as do MPO implants of estradiol (E2) (if an
androgen source is present) (Michael et al., 1973; Baum et al., 1973; McGinnis et al
1989) and dihydrotestosterone (DHT) (if an estrogen source is present) (McGinnis, 1989;
Naftolin et al., 1972; Baum, 2003). Under normal circumstances, T is converted into E2
by aromatase in the brain (Powers et al., 1987; Naftolin et al., 1972) and aromatase
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mRNA is expressed in the MPO (Roselli et al., 2000). Testosterone is also converted in
the testis or the brain into DHT by 5 alpha-reductase (Whalen et al., 1985; Martini, 1982;
Massa, et al 1981). Castrated rats treated with either E2 alone or DHT alone fail to
express the full repertoire of copulatory behavior (Wallis et al., 1975; Per Sodersten,
1973). However, castrated rats displayed normal mating behavior to ejaculation after
being treated with a combination of E2 and DHT and their mating behavior was equal to
that of rats treated with T (Michael et al., 1973; Baum et al., 1973). Implants of 1,4,6androstatriene-3,17-dione (ATD), a steroidal aromatase inhibitor, plus TP in the MPO
hinder copulatory behaviors, but implant of ATD with estradiol benzoate (EB) in the
MPO promote copulatory behavior (Watson et al., 1989). It is worth mentioning,
however, that ATD may compete for receptor binding with steroids (Kaplan et al., 1989).
Furthermore, gonadectomized male rats treated s.c. with the combination of T and
fadrozole, a non-steroidal aromatase inhibitor that blocks the conversion of testosterone
to E2, failed to show copulatory behavior and exogenous E2 partially reversed this
(Bonsall et al., 1992; Roselli, et al 2003; Vagell et al., 1997). Similarly, infusion of
fadrozole to the MPO of gonadally intact male rats inhibited mating (Clancy, 1995),
whereas gonadally intact male rats treated with fadrozole s.c. together with E2 implants in
the MPO displayed normal copulatory behavior (Clancy, 2000). Collectively, these
findings suggest that E2 acts in the MPO and that this action is necessary to maintain
sexual behavior in male rats (Clancy et al., 2000; Clancy et al., 1995). The rat MPO
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contains more than one type of estrogen-sensitive neuron; some express estrogen receptor
alpha (ERα) (Shughrue et al., 1997; Kumar et al., 2006) others express estrogen receptor
beta (ERβ) (Krege et al., 1998; Greco, 1998) some express both ERα and ERβ (Abraham
et al., 2004; Nomura et al., 2003), others express an ER in the membrane that is Gprotein-coupled (Sinchak et al., 2001). After treatment with TP and dihydrotestosterone
propionate (DHTP), castrated male mice with estrogen receptor α knockout (ERαKO)
were able to mount and intromit, but were unable to ejaculate, suggesting a role for ERα
in control of ejaculation (Ogawa et al., 1998; Scordalakes et al., 2002). In contrast to
ERαKO, estrogen receptor β knockout (ERβKO) castrated male mice showed relatively
normal sexual behavior, similar to that of castrated wild type mice treated with TP and
DHTP (Ogawa et al., 1999) suggesting ERβ is not necessary. However, mice with
combined αβERKO failed to mate at all (Ogawa et al., 2000), so both ERα and ERβ may
play a role in the display of mating behavior. Placement of an antisense
oligodeoxynucleotide (AS-ODN) complementary to ERα mRNA into the MPO inhibits
the expression of ERα and reduces levels of mounting, intromission and ejaculation,
unlike control rats that had been infused in the MPO with saline or received AS-ODN in
the MEA, which mated normally to ejaculation (Paisley et al., 2006). This suggests that
E2 acts differently in different brain regions, ERα in MPO is necessary for male rat
mating behavior, and ERα is not necessary in the MEA (Paisley et al., 2006).
Collectively, the evidence from these studies suggest a major role for ERα in the
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control of male rat copulatory behavior and a lesser role for ERβ, but additional research
is required to determine the exact roles of the these receptor subtypes in the control of
mating and to determine where in the brain each subtype may play a role. We
hypothesize that ERα in the MPO is sufficient to promote copulatory behavior in
castrated male rats treated s.c. with DHT. MPO implants of PPT were used to rather than
systemic administration of PPT because we hoped to test where in the brain PPT might
act. Therefore, we compared the effects on ejaculation of implants to the MPO of either
E2 or propyl-pyrazole triol (PPT) (Stauffer et al., 2000), a selective estrogen receptor α
agonist, in sexually experienced castrated male rats receiving DHT s.c., which supplied
the whole brain with a necessary non-aromatizable androgen source. We predicted that
PPT would be as effective as E2 at maintaining male rat mating behavior, demonstrating
the behavioral relevance and sufficiency of ERα activation in the MPO.

MATERIALS AND METHODS
Animals
Thirty Sprague Dawley male rats and fifteen female rats were allowed free access
of food and water and kept in cages (22 X 44 X 50 cm) in the Georgia State University
vivarium, at a temperature between 200-230 Centigrade and humidity of 43-56%. The rats
were maintained on 14:10 hours reverse light: dark cycle (light off at 9:30 AM EST).
Male rats lived two per cage until surgery after which they are housed signaly and
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females were housed two per cage throughout the study. Animal care was in accordance
with humane standards (NIH publ. No. 85-23, revised 1985) and all procedures involving
animals were authorized by the Georgia State University IACUC.
Female rats surgical procedures
Stimules females were anesthetized with isoflurane gas in a chamber (5% gas and
5 LPM oxygen exchange rate) and transferred to a nosecone (2-3% gas and 3 LPM
oxygen). Ovaries were removed through an abdominal incision and rats were implanted
in the scapular region s.c with a Silastic capsule (6mm length, 1.981 mm i.d. x 3.175 mm
o.d.) containing crystalline E2 (Clancy et al., 1995). Females were allowed at least five
days to recover from surgery before they were paired with male rats to measure sexual
behavior in the males. Four hours prior to each weekly behavioral test, females were
injected s.c. with 1 mg progesterone in 0.2 ml of sesame oil to induce sexual receptivity.
Male behavior screening, surgical procedures, and testing
Thirty male rats were screened once weekly for three consecutive weeks for the
display of sexual behavior prior to being selected in the experiment. Tests for sexual
behavior were conducted by blind observers once a week, 30 minutes per test. Sex testing
took place under red light illumination during the dark phase of the light: dark cycle. The
recorded behaviors included: mount frequency (MF): number of mounts with no
penetration, intromission frequency (IF): numbers of intromission with penetration,
ejaculation frequency (EF): numbers of ejaculation, mount latency (ML): time from test
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start until the first mount or intromission or 1800 seconds if mounts did not occur,
ejaculation latency (EL): time from first mount or intromission until the first ejaculation
or 1800 seconds if ejaculation did not occur, post ejaculatory interval (PEI): the time
between the first ejaculation and the next mount or intromission or 1800 seconds if
ejaculation did not occur, hit rate (HR): the percentage of mounts accompanied by
intromission and inter-mount interval (IMI): average time between consecutive mounts or
intromissions during the first mount bout or 1800 for non-ejaculations. (Clancy, A. N.,
Zumpe, D., and Michael, R. P. 2000; Liu, Y., Salamone, J. D., and Sachs, B. D. 1997).
Thereafter, male rats were assigned into three matched groups based on ejaculation
frequency: (i) PPT (n=7), (ii) E2 (n=8) or (iii) cholesterol (n=7). All three groups were
implanted in the MPO with the appropriate drug. Specifically, males were anesthetized
with isoflurane gas in a chamber (5% gas and 5 LPM oxygen exchange) and transferred
to a nosecone (2-3% gas and 3 LPM oxygen exchange). Anesthetized rats were castrated
through abdominal incisions and received s.c. a Silastic capsule containing crystalline
DHT (15 mm length, 1.981 mm i.d. and 3.175 mm o.d.) in the scapular region. They were
then placed in sterotaxic instrument and implanted bilaterally with 22 gauge guide
cannulae aimed at the MPO. (Level skull coordination: anterior posterior = -0.5 mm,
medial lateral= ± 0.75 mm, dorsal ventral = – 8.0 mm Swanson et al., 1998). 28 gauge
inner cannulae, extended 1 mm below guide cannulae. These were tamped in either E2,
PPT or cholesterol to deliver the drug into the MPO. Thereafter, rats were allowed at
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least five days to recover from surgery and postoperative behavioral testing began. Sterile
inner cannulae were replaced 48 hours before and 24 hours after each behavior test under
brief isoflurane anesthesia. Tips of cannulae were examined microscopically after they
were removed from the brain to insure drug was present and all cannulae passed this
inspection.
Histology
After completion of behavior testing, cannulae placements were confirmed by
histology. Males were euthanized with lethal doses of Nembutal, (sodium pentobarbital
l2 ml/kg, i.p, Abbott Laboratories), and transcardially perfused with saline, followed by
300 ml of fixative (4% paraformaldehyde, in 0.1 M phosphate buffer). Brains were then
immersed in fixative for at least 24 hours, transferred to 30% sucrose in 0.1 M phosphate
buffer for at least two days and cut coronally into 40 μm sections on a freezing
microtome. Sections were stained with thionin and locations of the cannulae tips were
mapped as black spots onto standard atlas plates.
Statistical analyses
Repeated measures (groups x trials) analysis of variance (ANOVA) was used for
statistical comparisons among the groups (Kirk, 1968). Follow-up post-hoc analysis
(Tukey honesty significant differences test, α = 0.05) was used to identify significant
group differences. Paired t-tests were used to compare within group changes in each
group between the third pre-operative behavior test (terminal pre-operative performance)
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and the fourth post-operative behavior test (terminal post-operative performance). Two
tailed probabilities are reported in all cases.
RESULTS

Behavior
Both estradiol and PPT implants to the MPO maintained the mating behavior of
sexually experienced, castrated male rats receiving DHT s.c. but cholesterol MPO
implants were ineffective. Thus, the two groups receiving either estradiol or PPT MPO
implants mated vigorously and were statistically indistinguishable from each other on all
measures of copulatory behavior during both the preoperative and postoperative periods;
moreover, sexual behavior did not change significantly in either of these two groups in
the periods before and after surgery. In contrast, sexually experienced, castrated, DHTtreated males that received MPO cholesterol implants virtually ceased mating during the
postoperative period and was significantly lower than that of either of the other two
groups on all measures of copulatory behavior, although, during the preoperative period,
they had copulated robustly and did not differ significantly on any behavioral measure
from the rats in the other two groups. Moreover, all measures of sexual behavior declined
significantly in the cholesterol MPO group during the period after surgery relative to
preoperative levels.
During the postoperative period (FIGURE 1), the groups differed significantly
from each other on mount frequency (F2,19 = 10.23, p < 0.001), intromission frequency
(F2,19 = 10.80, p < 0.001), ejaculation frequency (F2,19 = 10.98, p < 0.001) and hit rate
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(F2,19 = 9.31, p < 0.002). Moreover (FIGURE 2), during the postoperative period, the
groups also differed significantly from each other on mount latency (F2,19 = 13.80, p <
0.0001), ejaculation latency (F2,19 = 6.66, p < 0.007), inter-mount interval (F2,19 = 6.86, p
< 0.006) and the post-ejaculatory interval (F2,19 = 8.12, p < 0.003). No other statistically
significant main effects or interactions were observed during the postoperative period.
Follow-up post-hoc analysis of behavior during the postoperative period revealed no
significant differences on any test day between the estradiol and PPT groups on any of
the eight behavioral measures, however, mount frequency in the cholesterol group was
significantly lower than that in each of the other two groups on the second (p < 0.05) and
third (p < 0.05) days; on intromission frequency, the cholesterol group was significantly
lower (p < 0.05) than the estradiol group on all four trials and lower than the PPT group
on the second and fourth trials (p < 0.05, respectively); and on hit rate, the cholesterol
group was significantly lower (p < 0.05) than the PPT group on the fourth day (FIGURE
1). Similarly (FIGURE 2), during postoperative trials, the cholesterol group exhibited
significantly longer mount latencies than the estradiol group on the second, third and
fourth days and PPT group on the second and fourth days (p < 0.05, respectively); on
ejaculation latency, the cholesterol group was significantly (p < 0.05) higher than the
estradiol group on the second day; and with respect to the inter-mount interval and the
post-ejaculatory interval on the second postoperative trial, the cholesterol group showed
significantly longer latencies than both the estradiol and PPT groups (p < 0.05,
respectively).
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There were no significant group differences on any of the eight measures of
copulatory behavior during the preoperative trials, nor were there any significant
interactions. Significant behavioral differences emerged, however, as the days of testing
progressed during the preoperative period. Specifically, mount frequency scores (F2,38 =
24.76, p > 0.0001) and intromission frequency scores (F2,38 = 22.93, p > 0.0001)
improved significantly as preoperative testing advanced (FIGURE 1), whereas mount
latency scores decreased significantly (F2,38 = 12.90, p > 0.0001) during the preoperative
period.
Changes in sexual behavior within each group were examined by comparing the
performances on the last preoperative testing day and the last postoperative testing day.
There were no significant changes on any of the eight indices of copulatory behavior in
the groups that received MPO implants of either estradiol or PPT, however, on all eight
measures of mating, sexual behavior deteriorated significantly during the postoperative
period in the group implanted with cholesterol to the MPO. Specifically, in the
cholesterol group, mount frequency (t = 8.15, df = 6, p < 0.0002), intromission frequency
(t = 6.05, df = 6, p < 0.0009), ejaculation frequency (t = 4.80, df = 6, p < 0.003) and hit
rate (t = 2.84, df = 6, p < 0.03) were significantly depressed on the last postoperative test
compared with the last preoperative day (FIGURE 1), whereas mount latency (t = 3.99,
df = 6, p < 0.007), ejaculation latency (t = 2.88, df = 6, p < 0.03), inter-mount interval (t =
3.94, df = 6, p < 0.007) and the post-ejaculatory interval (t = 4.73, df = 6, p < 0.003) were
significantly lengthened on the last postoperative test relative to the last preoperative day
(FIGURE 2).
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Histology
Locations of the cannulae tips were mapped as black spots onto standard atlas
plates; all cannulae tips were located in the MPO or anterior hypothalamus (FIGURE 3).
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FIGURE 1: Mount frequency, intromission frequency, ejaculation frequency, and hit rate
percentage.
Mean ± standard error of the mean (SEM) mount frequency, intromission frequency,
ejaculation frequency, and hit rate in weekly, 30 min sex tests. During the post operative
but not preoperative periods the groups differed significantly on each of these behavioral
measure (See text for F values).
*: Between-group comparison: cholesterol differs significantly from E2, p < 0.05.
+: Between-group comparison: cholesterol differs from PPT, p < 0.05.
X: Cholesterol within group comparison, p < 0.05.
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FIGURE 1
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FIGURE 2: Mount latency, inter-mount interval, ejaculatory latency, and post ejaculatory
interval.
In seconds, mean ± SEM mount latency, inter-mount interval, ejaculatory latency, and
post ejaculatory interval in weekly, 30 min sex tests. During the post operative but not
preoperative periods the groups were differed significantly on each of these behavioral
measure (See text for F values).
*: Between-group comparison: cholesterol differs significantly from E2, p < 0.05.
+: Between-group comparison: cholesterol differs from PPT, p < 0.05.
X: Cholesterol Within group comparison, p < 0.05.
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FIGURE 2

16

FIGURE 3: Cannulae Placement.
The cannulae tips were located in the MPO or anterior hypothalamus (AH). The
distribution of cannulae tips in the MPO was mapped on a standard series of coronal atlas
plates through the MPO and anterior hypothalamus. Dots represent locations of cannulae
tips from each animal.
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FIGURE 3

18

DISCUSSION
In this study, we compared the copulatory behavior of sexually experienced,
castrated rats treated with DHT s.c that received MPO implants of either PPT, an
estrogen receptor α agonist, E2 or cholesterol. PPT treated rats displayed comparable
levels of mating behavior to those treated with E2, whereas mating virtually ceased in
cholesterol treated animals as shown in other studies (Rosenblatt et al., 1998). These
findings support the hypothesis that ERα in the MPO is sufficient to promote mating
behavior in castrated male rats treated s.c. with DHT. PPT is thought to activate ERα
only whereas E2 activates both ERα and ERβ yet rats treated with PPT mounted,
intromited and ejaculated at rates that were statistically indistinguishable from those
treated with E2. In the cholesterol group, on the other hand, presumably neither ERα nor
ERβ were activated and these rats virtually ceased mating.
A critical region of the brain for male copulation control is the MPO, as much
prior research has shown (Clancy et al., 2000; Clancy, et al., 1995; Bonsall et al., 1992;
Morali, 1986). Steroid sensitive neurons in the MPO are activated by mating (Greco et
al., 1998), including those expressing androgen receptors (Greco et al., 1999), ERα and
ERβ (Shughrue et al., 1997; Kumar et al., 2006; Krege et al., 1998; Greco, 1998) and
there is much evidence suggesting that ERα is the behaviorally relevant ER (Ogawa et
al., 1998; Scordalakes et al., 2002; Paisley et al., 2006). The present results demonstrate
that activation of ERα in the MPO is sufficient to promote copulatory behavior in
castrated DHT treated male rats. Specifically implants of the MPO with PPT, a selective
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ERα agonist, supported mating equally as well as E2, which stimulates both estrogen
receptor α and β.
In human cell culture, PPT binds ERα with the same affinity as E2 binds ERα and
has zero cross reactivity with ERβ (Stauffer et al., 2000) (FIGURE-4).
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FIGURE 4: PPT binds to ERα but not ER β.
“Transcription activation by ERα (left) and ERβ (right) in response to pyrazole 4c (PPD)
and 4g (PPT). Human endometrial cancer (HEC-1) cells were transfected with expression
vectors for ERα or ERβ and an (ERE) 3-pS-CAT reporter gene and were treated with the
indicated concentrations of ligand for 24 h. CAT activity was normalized for βgalactosidase activity from an internal control plasmid. Values are expressed as a percent
of the ERα or ERβ response with 2 nM E2, which is set at 100%’’ (Stauffer et al., 2000).
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Stauffer et al., 2000

FIGURE 4
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Ligands such as PPT or estradiol bind selectivity to receptors depending on the
ligand binding pocket, cofactors, estrogen response elements and their promoters and
other factors (Wright et al., 2006). For example, ERα has in its ligand binding pocket Met
421 and ERβ has lle 373; the ERα ligand binding pocket is occupied by Leu384, on the
other hand, ERβ has Met 336 (Wright et al., 2006; Katzenellenbogen et al., 2000). PPT is
formed from pyrazole attached at C3 and C5 with phenol, N1 phenyl and C4 with propyl
group (Wright et al., 2006). The hydroxyl portion of the phenol group at C3 and C5 have
no charge and can react with the hydrophilic side chain of other compounds in order to
form hydrogen bonds (Stauffer et al., 2000). Both the nitrogen groups at C1 and C2 also
have no charge and they can form a hydrogen bond with hydrophilic side chain of the
receptor proteins or water (Stauffer et al., 2000).
In vitro experiments demonstrate that ERα, but not ERβ, bind to PPT. Relative
binding affinity is measured after replacing the R (alkyl group) with different alkyl
groups and the X (halogen group) is replaced with hydrogen or hydroxy groups (Stauffer
et al., 2000). These competitive radiometric binding assays were measured in human ERα
and ERβ (Stauffer et al., 2000). The assay showed that PPT has greater affinity toward
ERα by 410 fold than to ERβ (Stauffer et al., 2000). The ability of PPT to activate
transcription of ERα or ERβ genes were demonstrated in human endometrial cancer cells
(Stauffer et al., 2000). The potency selectivity between ERα/ERβ to PPT indicates that
PPT binds to ERα with greater potency than ERβ (Stauffer et al., 2000).
PPT has been used in various experiments as an ERα agonist. For instance, PPT
activates ERα, whereas diarylpropionitrile (DPN) activates ERβ, in hippocampus in vitro
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and in vivo (Wang et al., 2006). Activation of ERα via PPT promotes the formation of
apolipoprotein E4 (ApoE4) which is associated with Alzheimer’s disease (AD),
triggering an increase in low-density lipoprotein (LDL), and neurodegenerative disease
(Harris et al., 2003). On the other hand, the ERβ agonist, DPN, inhibits ApoE4 and
activates apolipoprotein E2 (ApoE2) and apolipoprotein E3 (ApoE3), which is linked to a
reduced risk of AD (Wang et al., 2006). Similar observations were also seen in immature
mice that had been injected with PPT; PPT increased uterus weight (Frasor et al., 2003).
Collectively these studies demonstrate that PPT activates at least three different genes
that include complement component 3 (C3), lactoferrin, and glucose-6-phosphate
dehydrogenase (G6PDH) in the uterus (Frasor et al., 2003).
Our new finding extends previous reports showing that blockade of ERα
expression in the MPO impaires mating behavior (Paisley et al., 2006). Specifically
infusion of the MPO with an antisense oligodeoxynucleotide sequence complementary to
ERα mRNA reduced expression of ERα and sexual behavior in male rats (Paisley et al.,
2006), suggesting a role for ERα in control of mating behavior. Similarly, male ERα
knockout mice also show reduced mating behavior (Ogawa et al., 1998; Scordalakes et
al., 2002). The present findings complement these earlier reports by demonstrating that a
selective ERα agonist drug maintains behavior equally as well as E2, which suggests the
behaviorally relevant ER in the male rat MPO is ERα with respect to mating behavior.
Each behavior we observed, MF, IF, EF, ML, EL, PEI, HR and IMI, is maintained
by E2 activation of ER in the MPO and specifically by ERα, since PPT MPO implants
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were as effective as E2 MPO implants at promoting mating in gonadomatized male rats
treated with exogenous DHT, but cholesterol MPO implants were ineffective.
It is pertinent that T is converted into E2 through aromatization (Naftolin et al.,
1972; Powers et al., 1987), and DHT is formed from T through the action of 5-α
reductase (Martini, 1982; Massa, et al., 1981; Whalen et al., 1985). Exogenous T in
physiological concentrations is sufficient to promote copulatory behavior in castrated
male rats, and combined treatment with E2 and DHT, each in physiological concentration,
is as effective as T in promoting sexual behavior (Michael et al., 1973; Baum et al., 1973;
McGinnis et al 1989; McGinnis, 1989; Naftolin et al., 1972; Baum, 2003). In contrast,
sexual behavior is poorly maintained by either E2 alone or DHT alone except if
substantially in higher doses in the pharmacological range are administered (McGinnis,
1989). It is noteworthy that T must be converted into E2 and DHT to maintain sexual
behavior in castrated rats and if this conversion of T to E2 is blocked, then sexual
behavior is depressed (Naftolin et al., 1972; Baum, 2003; Bonsall et al., 1992). E2 acts in
the brain by binding to estrogen receptors whereas T and DHT bind to androgen
receptors. Both estrogen receptors and androgen receptors are found in different regions
of the brain, including the MPO, supraoptic nucleus, ventral zone of medial parvicelullar
part of the paraventricular nucleus of hypothalamus and lateral cerebellar region (Simerly
et al., 1990). Since, both ER and AR reside within the MPO (Handa et al., 1996), both
ER and AR containing neurons have the potential to mediate male rat mating.
There are at least two ways that E2 may affect its targets, either by activating the
genome or via a non-genomic pathway; many questions remain concerning how estrogen
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acts in the MPO. One neuronally mediated estrogen dependent response that has received
considerable attention is the estrogen activation, via ERα, of MPO dopamine circuits
(Scordalakes et al., 2002; Putnam et al., 2005). It has been proposed that E2 activation of
ERα enhances the formation of neuronal nitro oxide synthase (nNOS) (Scordalakes et al.,
2002) which converts L-arginine into citrulline and nitric oxide (NO) (Palmer et al.,
1988). NO, in turn, triggers the release of dopamine (DA) (Scordalakes et al., 2002;) in
the MPO. This increase in dopamine in the MPO elicits erection and ejaculation (Hull et
al., 1992; Hull et al., 1989; Dominguez et al., 2004; Hull et al., 1999; Putnam et al.,
2005). There is also a negative feed back mechanism whereby elevated levels of NO
inhibit aromatase, which limits further production of E2 from T (Snyder et al., 1996).
Castrated animals tend to have decreased nNOS but exogenous administration of T or E2
reverses this effect of castration and nNOS subsequently increases (Du, et al., 1999;
Putnam et al., 2005). Furthermore, castration also decreases the release of DA from the
MPO and this is due to lack of NO in the MPO (Du, et al., 1998). Immunocytochemical
studies have demonstrated the coexpression of AR, ERα and nNOS in the MPO (Sota et
al., 2005). Implantation of the nitro oxide synthase (NOS) inhibitor, N-monomethyl-Larginine (L-NMMA), blocked the expression of NO in the MPO and reduced the mount
rate. Conversely, administration of L-arginine, a NO precursor, in the MPO promoted an
increase of mounting in male rats (Sota et al., 1998), whereas blocking the synthesis of
NOS in an intact rat inhibits the formation of DA and lowered mating behavior (Hull et
al., 1997).
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Castrated male rat failed to achieve erection following electrical stimulation of
MPO, but implant of T in the MPO reinstated erection (Suzuki et al., 2007; Giuliano,
1997). This suggests that MPO plays a role in an erection in response to T (Suzuki et al.,
2007). Stimulation of dopamine receptor 1 (D1) in the MPO enhanced erection by
activating parasympathetic pathways, and dopamine receptor 2 (D2) in the MPO
operating through a sympathetic pathway to elicit ejaculation (Hull et al., 1992; Hull et
al., 1989; Dominguez et al., 2004).
In the conclusion, there is much evidence suggesting that ERα is the behaviorally
relevant ER for mating. We demonstrated that activation of ERα in the MPO is sufficient
to promote copulatory behavior in castrated DHT treated male rats. We implanted PPT, a
selective ERα agonist, in MPO which maintained mating behavior equally as well as E2,
(which stimulates both ERα and ERβ). Sexual behavior data gathered from this PPT
study suggests that ERα is the ER in the MPO that is sufficient for display of mating
behavior. Further investigation is required to identify whether MPO ER acts as a
membrane receptor or whether it acts as transcription factor in promoting sexual
behaviors. More studies will be required to determine other sites in the brain where PPT
may act and to test if its effects in the MPO are specific by incorporating anatomical
controls and by examining the MPO more closely to see if PPT has selective effects in
different sub regions of the MPO. However, recent finding in our laboratory indicated
that castrated, DHT treated male rats implanted with E2 conjugated to bovine serum
albumin (BSA) in the MPO were able to mate normally (Huddleston et al., 2006,
Personal communication). This raises the possibility that ERα associated with the plasma
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membrane of MPO neurons may mediate the responses to E2 that underlie male rat
capulatory behavior.
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